Drosophila mixed lineage kinase/slipper, a missing biochemical link in Drosophila JNK signaling  by Sathyanarayana, Pradeep et al.
Drosophila mixed lineage kinase/slipper, a missing biochemical
link in Drosophila JNK signaling
$
Pradeep Sathyanarayanaa, Manoj K. Barthwala, Mary Ellen Laneb, Summer F. Acevedoc,
Efthimios M.C. Skoulakisc, Andreas Bergmannd, Ajay Ranaa,*
aThe Division of Molecular Cardiology, Cardiovascular Research Institute, College of Medicine, The Texas A&M University System HSC,
1901 South 1st St. Bldg.162 Temple, TX 76504, USA
bDepartment of Biochemistry and Cell Biology, Rice University, Houston, TX 77251, USA
cDepartment of Biology, Texas A&M University, College Station, TX 77843, USA
dDepartment of Biochemistry and Molecular Biology, M.D. Anderson Cancer Center, University of Texas, Houston, TX 77030, USA
Received 5 November 2002; received in revised form 21 January 2003; accepted 24 January 2003
Abstract
Mixed lineage kinases (MLKs) belong to the family of mitogen activated protein kinase kinase kinase (MAPKKK) and cause neuronal
cell death mediated through c-Jun, N-terminal kinase (JNK) pathway. Recently, genetic studies in Drosophila revealed the presence of an
MLK termed slipper (slpr). However, its biochemical features like physiological substrate, role in different MAPK pathways and
developmental and tissue-specific expression pattern were not reported. Here, we report cDNA cloning, expression analysis and biochemical
characterization of a Drosophila mixed lineage kinase (dMLK) that is also known as slipper. The protein structure analysis of dMLK/slipper
revealed, in addition to the conserved domains, a stretch of glutamine in the amino terminus and an asparagine–threonine stretch at the
carboxy-terminus. In situ hybridization and reverse transcriptase polymerase chain reaction (RT-PCR) analysis revealed that dMLK is
expressed in early embryonic stages, adult brain and thorax. Ectopic expression of dMLK either in Drosophila S2 or in mammalian HEK293
cells leads to activation of JNK, p38 and extracellular signal regulated kinase (ERK) pathways. Further, dMLK directly phosphorylates Hep,
dMKK4 and also their mammalian counterparts, MKK7 and SEK1, in an in vitro kinase assay. Taken together, our results provide for the first
time a comprehensive expression profile and new biochemical insight of dMLK/slipper.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Mitogen activated protein kinases (MAPKs) are evolu-
tionarily conserved signal transducing enzymes that regulate
diverse cellular responses to a number of extracellular
stimuli. MAPKs function through a three-tiered cascade
composed of a MAPK, MAPK kinase (MAPKK) and a
MAPKK kinase (MAPKKK) [1]. So far, four distinct
groups of MAPK cascades have been identified, which
include the extracellular signal regulated kinase (ERK)
pathway, c-Jun, N-terminal kinase (JNK) pathway, the p38
pathway and the ERK5/big MAPK1 (BMK1) pathway [1].
Mixed lineage kinase (MLK) family members in verte-
brates and specially in mammals have been shown to
function as mitogen activated protein kinase kinase kinases
(MAPKKKs), which primarily activate the JNK pathway,
also called as stress activated protein kinase pathway
(SAPK) [2]. The MLKs are so called because their catalytic
domain contains signature sequences of both Ser/Thr and
tyrosine kinases [2]. Members of this family comprise
MLK1 [3], MLK2/MST [4,5] MLK3/SPRK/PTK1 [6,7],
MLK4-a and -h [8], dual leucine zipper kinase (DLK/
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MUK/ZPK) [9–11], leucine zipper bearing kinase (LZK)
[12], AZK [13], MLTK-a/MLK7 [14,15] and MLTK-h
[15]. The first subgroup of MLKs that includes MLK1–4
has an N-terminal Src-homology 3 (SH3) domain followed
by a kinase domain, dual leucine zipper domain and a
Cdc42/Rac interactive binding (CRIB) domain. DLK/
MUK/ZPK and LZK belong to the second subgroup that
does not contain either SH3 or CRIB domains. The third
subgroup, comprising AZK and MLTK, possesses an exclu-
sive sterile alpha motif (SAM) close to their C terminus.
MLKs in general are potent activators of JNK pathway,
however, other members like MLK2 [5], MLK3 [2], DLK
[16] and MLTK [15] can moderately activate p38 MAPK
upon overexpression. In addition, MLK2 [5] and MLTK
[15] have been shown to activate the ERK pathway when
overexpressed.
The diversity and complexity at the MAPKKK level in
mammals has made it very difficult to link each MAPKKK
member to specific stimuli [1]. Drosophila has helped to
define many complex biochemical pathways in vertebrates
especially in mammals because of fewer isoforms for a
given protein [17]. The JNK pathway in vertebrates and
Drosophila is relatively conserved [18], where the intact
JNK pathway in Drosophila is required for the morphoge-
netic process of dorsal closure and also in controlling planar
polarity in several tissues [19]. Genetic studies in Droso-
phila have helped to identify hemipterous (Hep) [20] and
Basket (Bsk) [21] as MAPKK and MAPK members within
the dJNK pathway, but the identity of MAPKKK member
was not known. Recently, a Drosophila homolog of mam-
malian MLK gene called slipper (slpr) has been shown to be
involved in dorsal closure [22]. However, any direct bio-
chemical evidence to classify slpr as the MAPKKK member
like its mammalian counterparts, its role in activating
Drosophila MAPK pathways and the expression pattern
were lacking.
Since mammalian MLK members act like MAPKKK in
the JNK pathway and so far, no MLK member in Droso-
phila JNK pathway was biochemically defined, the primary
objective of this study was to clone a cDNA of Drosophila
MLK and biochemically characterize its role in Drosophila
JNK signaling. Here, we present cloning and biochemical
characterization of Drosophila mixed lineage kinase, dMLK
(GenBank accession number AAF416233), which is also
known as slipper [22]. Our results show that dMLK/slipper
can directly phosphorylate Hep as well as dMKK4 and thus
act upstream of the Hep/Bsk cascade culminating in JNK
activation. Our studies in Drosophila Schneider 2 (S2) cells
and mammalian human embryonic kidney 293 (HEK293)
cells demonstrate that overexpression of dMLK activates
JNK, p38 and ERK pathways. Developmental expression
profile analyzed through reverse transcriptase polymerase
chain reaction (RT-PCR) and in situ hybridization revealed
that dMLK is expressed in early embryonic stage and in
adult head and thorax. In this report, we provide for the first
time a biochemical insight and expression profile about
dMLK/slipper and its potential in understanding the role of
mammalian MLKs in both physiological and pathological
conditions.
2. Materials and methods
2.1. Molecular cloning of dMLK/slipper
PCR primers, dMLK (forward) 5VGGGGTACCA-
TGCTGCCGATCAGCGAG3V and dMLK (Reverse)
5VTCCCCGCGGGCATCGCTCCAGTTGCTC3V, were syn-
thesized from two flanking exons of the Drosophila gene
CG2272 as reported in GenBank. A Drosophila cDNA
library in ZapII, made from 0–22-h embryo (LD library)
was obtained from Berkeley Drosophila Genome Project
[23]. The library was amplified once in E. coli strain
BB4 (Stratagene, CA) and phage DNA was extracted
according to published protocol [24]. The amplified cDNA
library was used as a template and a PCR reaction was
performed using Expand Long Template PCR System
(Roche, IN) in the presence of dMLK forward and dMLK
reverse primers. The PCR amplified product was digested
with KpnI and SacII restriction enzymes and cloned into
mammalian expression vector pcDNA3.1/Myc-His (Invi-
trogen, CA). The entire cDNA was sequenced and com-
piled (GenBank #AF416233).
2.2. RT-PCR analysis and in situ hybridization
Twenty heads, thoraces and abdomens or equivalent
amounts of embryos, larvae or pupae were homogenized
in 100 Al of Trizol (GIBCO BRL) and total RNA was
isolated. Reverse transcription (RT) was performed using
200 units of Moloney murine leukemia virus H ( ) Point
Reverse Transcriptase (Promega, Madison, WI). Close to
20% of each RT product was taken as template for PCR
amplification with Taq polymerase (Roche) and the reac-
tions were performed for 45 cycles with the profile: 92 jC
for 45 s, 50 jC for 1 min and 72 jC for 1 min. The reverse
transcription quality and quantity was monitored by ampli-
fication of Drosophila 14-3-3~ (leonardo) transcripts. The
mushroom body ablated flies were obtained and verified
histologically using published methods [25]. Fly broods that
yielded greater than 90% ablation were used for the RT-
PCR. RNA in situ hybridization was performed using
standard protocols [26].
2.3. Subcloning, expression and recombinant protein
purification
The dMLK/slipper cDNA was subcloned in frame in
Drosophila expression pAC5.1/V5-His vector (Invitrogen).
For expression in HEK293 cells, 2 Ag of pcDNA3.1/Myc-
His, dMLK cDNA or pEBG-BxB-Raf-1 cDNA was trans-
fected by using Lipofectamine reagent following manufac-
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turer’s (Invitrogen) protocol. The Drosophila S2 cells were
transfected with 2 Ag of pAc5.1/V5-His. dMLK (WT) by
calcium phosphate transfection method following a protocol
from Invitrogen and cells were harvested 40–48 h post
transfection. The recombinant SEK1 (K-R)/MKK4 (K-R),
MKK7 (Ala), dMKK4, Hep and MEK1 proteins were
expressed as a glutathione S-transferase fusion protein in
bacterial strain BL21 (Pharmacia, NJ). The recombinant
proteins were purified over GSH-sepharose column (Phar-
macia), eluted with reduced glutathione, dialyzed and stored
at  20 jC in 50% glycerol.
2.4. Immunoprecipitation and kinase assay
HEK293 or S2 cells were homogenized using a glass
homogenizer in lysis buffer and cell lysates were prepared
as described earlier [2]. The recombinant dMLK from
HEK293 cell extracts were immunoprecipitated using pro-
tein A sepharose preabsorbed with antibody (9E10) against
Myc-tag. The dMLK from S2 cell extract was immunopre-
cipitated by protein A sepharose preabsorbed with anti-V5
antibody (Invitrogen). Recombinant active Raf-1 was a kind
gift of Dr. Guri Tzivion (Texas A&M University-HSC).
Kinase assay was performed as described earlier [2] in
presence of either GST-SEK1 (K-R)/MKK4 (K-R) or
GST-MKK7 (Ala) or GST-dMKK4 or GST-Hep as the
substrates.
2.5. Immunoblotting
The proteins were separated on denaturing SDS/PAGE
and transferred on to PVDF membrane and blotted with
antibodies as indicated. Anti phospho-JNK was purchased
from Promega; anti phospho-MAPK and anti phospho-p38
were obtained from Cell Signaling Technology (Beverly,
MA). Anti JNK (cat #sc-571), anti p38 (cat #sc-728) and
anti MAPK (cat #sc-94) were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Antibody against V5 tag
was obtained from Invitrogen, antibody against GST was
obtained from Upstate Biotechnology and antibody against
Myc tag (9E10) was provided by Dr. Joseph Avruch
(Massachusetts General Hospital, Boston).
3. Results
3.1. Molecular cloning of dMLK/slipper
Almost all the mammalian MLKs identified so far share
very high homology in their catalytic domain and contain
sequences common to serine/threonine and tyrosine kinases.
To identify the mammalian MLK homolog in Drosophila,
we performed BLAST search in the Drosophila genome
database using complete amino acid sequence of human
mixed lineage kinase 3 (MLK3) [6]. The BLAST search
retrieved a Drosophila gene product (GenBank accession
number AAF46344) on the X chromosome having 45%
identity and 58% similarity to the MLK3 protein sequence,
which we named Drosophila mixed lineage kinase (dMLK).
dMLK showed a very high homology within the kinase
domain to mammalian MLKs. To obtain a complete cDNA
sequence of dMLK, a Drosophila embryonic cDNA library
was used for PCR-based cloning strategy. Two oligonucleo-
tide primers (see Section 2) were designed from two flank-
ing exons of the predicted gene product, CG2272, and PCR
was performed using a cDNA library prepared from 0–22-h
Drosophila embryos as the template [23]. A PCR product of
3447 basepair was amplified and cloned into a mammalian
expression plasmid vector. The amplified dMLK cDNAwas
sequenced from both the ends, which revealed that the
coding sequence contains two additional exons (Fig. 1A),
which were initially predicted as introns in the database at
the National Center for Biotechnology Information (NCBI).
It is known that the Genie and Genscan programs used to
Fig. 1. Identification of the Drosophila homolog of human mixed lineage kinases, dMLK/slipper. (A) Predicted and deduced exon– intron organization of
dMLK. (a) Predicted structure of gene CG2272 (GenBank #AE003443); (b) exon– intron boundaries revealed by dMLK cDNA (GenBank #AF416233). (B)
Protein domains of dMLK. Schematic representation of dMLK protein (GenBank #AAL08011) showing conserved domains (SH3 domain, Kinase domain,
Leucine zipper domain and CRIB domain) and also novel N-terminal glutamine-rich and C-terminal asparagine/threonine-rich regions.
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annotate the fly genomic sequence make systematic errors
with respect to intron–exon boundaries and gene borders
[27]. Since we used cDNA library source to amplify dMLK,
we could detect the discrepancy caused by those programs.
The protein structure analysis (Fig. 1B) of dMLK showed
that it contains an amino-terminal SH3 domain followed by
a kinase domain, a leucine/isoleucine zipper motif and a
CRIB domain similar to mammalian MLKs. However, the
carboxy terminal region of dMLK did not show any
significant homology to any known mammalian MLK
family members. The dMLK also contained a stretch of
glutamine in the amino terminus and an asparagine–threo-
nine stretch at the carboxy-terminus (Fig. 1B), which is not
present in any of the known mammalian MLK members.
3.2. Developmental expression analysis of dMLK/slipper by
RT-PCR
To examine the pattern of dMLK expression during
Drosophila development, we used RT-PCR analysis to
Fig. 2. Developmental expression pattern of dMLK/slipper by RT-PCR analysis. dMLK gene is highly expressed in Drosophila S2 cells, early embryonic
stages (1–3 h) and adult head and thorax. As a control, the levels of Leonardo transcripts (Leo I and Leo II) were also analyzed.
Fig. 3. In situ hybridization analysis of dMLK/slipper expression in embryos. (B, D, F, H) RNA in situ hybridization with dMLK anti-sense dioxygenin-labeled
probes was performed on wild-type embryos to localize dMLK transcripts in various stages of embryogenesis. (A, C, E, G) Equally staged embryos probed
with a dMLK sense probe as control to estimate background staining. (B) Large quantities of dMLK mRNA were detected in early (stage 4) embryos
suggesting that this transcript is provided maternally. (D, F, G) During the following stages, dMLK transcript becomes less abundant and is barely detectable by
the end of embryogenesis. Shown are stage 9 (D), stage 13 (F) and stage 16 (H) embryos.
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amplify dMLK using RNA isolated from different devel-
opmental stages and from specific organs of adult fly (Fig.
2). The transcripts of dMLK were detected in the early
embryo (1–3 h) but not in other stages of embryogenesis.
dMLK expression was also detected in adult head and
thorax, but not in abdomen. Drosophila S2 cells, which
are derived from embryonic epithelial cells, also express
dMLK. The levels of Drosophila 14-3-3 q (Leonardo)
transcripts (Leo I or Leo II) analyzed for normalization were
similar at all stages and in all organs (Fig. 2).
3.3. In situ hybridization of dMLK/slipper in Drosophila
embryos
The expression pattern of dMLK was also analyzed using
RNA in situ hybridization to embryos. In early embryonic
stages (stage 1–4), dMLK transcripts were present uni-
formly in large quantities (Fig. 3B), suggesting that it was
provided by the mother. In the late embryonic stages, dMLK
transcripts remain ubiquitously expressed (Fig. 3D, F and
H); however, its amount was dramatically reduced and was
barely detectable in late-stage embryos (Fig. 3H). There is
no specific up-regulation of dMLK transcript detectable in
parts of the embryo undergoing dorsal closure.
3.4. dMLK/slipper activates MAPKs
The overexpressed mammalian MLKs activate JNK
potently, however, some members can activate p38 and
ERK MAPKs. To examine whether dMLK behaves in a
similar fashion like its mammalian homologs, HEK293
cells were transfected with dMLK and the endogenous
JNK, ERK and p38 activations were measured using
antibodies directed against their phosphorylated (active)
forms. Overexpression of dMLK activated JNK in
HEK293 cells (Fig. 4) similar to MLK2 and MLK3
and was constitutively active like mammalian MLKs.
The overexpressed dMLK also activated ERKs and p38
like other mammalian MLKs (Fig. 4). Since dMLK
overexpression activated JNK, p38 and ERKs, we took
constitutive active Raf-1 (BxB Raf-1) and overexpressed
under similar conditions to demonstrate that the observed
effects of dMLK on three MAPK pathways were not an
artifact of overexpression. Constitutive active Raf-1 is
known to activate ERKs specifically under overexpressed
conditions. The constitutive active Raf-1 activated only
ERK but not JNK or p38 pathways (Fig. 4, lane 6),
proving that the observed results with dMLK overexpres-
sion on MAPKs were not an artifact of overexpression.
Fig. 4. Role of dMLK/slipper in MAPK and stress-induced signaling. (A) Overexpression of dMLK activates MAPKs. HEK293 and S2 cells were transiently
transfected with vector control or Myc-dMLK, M2-MLK3, Myc-MLK2 or V5-dMLK/slipper as indicated. HEK293 cells were also separately treated with 10
Ag/ml anisomycin, 100 ng/ml PMA and 0.7 M NaCl as positive controls for JNK, ERK and p38. The effect of dMLK on activation of endogenous JNK, ERK
and p38 was assayed using antibodies against activated forms of the corresponding MAPKs, and equal expression of MAPKs was examined using antibodies
against corresponding MAPKs as indicated.
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Similar type of results has been reported with another
mammalian MLK, MLTK: the overexpression of MLTK
causes activation of JNK, p38 and ERK MAPKs [15].
Since overexpression of dMLK activated JNK, p38 and
ERK activities in HEK293 cells, we thought that the
behavior of dMLK in cell lines derived from Drosophila
could be different. Unlike mammals, the Drosophila
genome database does not contain same number of
upstream regulators of MAPK pathways. To examine
the behavior of dMLK in Drosophila, S2 cells, a Dro-
sophila cell line that is derived from embryonic epithelial
cells, were transfected with dMLK expression vector. The
endogenous JNK, ERK and p38 activations were meas-
ured using antibodies against phosphorylated forms. The
overexpression of dMLK in S2 cells demonstrated a
similar pattern of MAPKs activation (Fig. 4) as seen in
the HEK293 cells, suggesting that at least in HEK293
and S2 cells, dMLK functions similarly irrespective of
the origin of the cells.
3.5. dMLK/slipper directly phosphorylates MEK members
in vitro
It has been reported that overexpression of dMKK4
activates JNK pathway similar to the mammalian SEK1/
MKK4 [28]. The Drosophila homolog of mammalian
MKK7 known as Hep has been shown to participate in
dorsal closure process in Drosophila [20], a characteristic
feature rendered by the deficiency in the components of
JNK pathway in fly [18]. To examine, whether dMLK
functions as MAPKKK, dMLK protein was expressed in
HEK293 and S2 cells and incubated with bacterially
expressed SEK1/MKK4 (K-R), MKK7(Ala), Hep and
dMKK4 proteins. The recombinant dMLK protein,
expressed either in HEK293 or in S2 cells, phosphorylated
both the mammalian (Fig. 5A and B) and Drosophila (Fig.
5C and D) MEKs in in vitro kinase assay. Since all the MEK
members within the mammalian or Drosophila JNK path-
ways were phosphorylated by dMLK, in order to rule out
Fig. 5. Recombinant dMLK/slipper phosphorylates mammalian and Drosophila MEKs. (A, B) Recombinant Myc-dMLK was immunoprecipitated from
transfected HEK293 cells using anti-Myc antibody (9E10) and was assayed for in vitro kinase activity in the presence of bacterially expressed recombinant
GST-SEK1 (K-R) (B) or GST-MKK7 (Ala) (C) proteins. (C, D) Recombinant V5-dMLK was immunoprecipitated from transfected Drosophila S2 cells using
antibody against the V5 tag and assayed for in vitro kinase activity in the presence of Drosophila GST-dMKK4 (D) and GST-Hep (E) proteins, expressed and
purified from bacteria. (E) Purified recombinant active Raf-1 was assayed for in vitro kinase activity in the presence of bacterially expressed recombinant GST,
GST-dMKK4, GST-Hep, GST-MKK7 (Ala) and GST-SEK1 (K-R) proteins. GST-MEK1, a known substrate of Raf-1, was used to assay the kinase activity of
active Raf1.
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any nonspecific in vitro phosphorylation, we parallely
carried out in vitro kinase assay taking active Raf-1
enzyme. Active Raf-1 was unable to phosphorylate GST-
Hep, GST-dMKK4, GST-MKK7 (Ala) and GST-SEK1
(K-R) but GST-MEK1, which is a known substrate of Raf-1,
was phosphorylated (Fig. 5E). These results suggest that the
phosphorylation of all the MEKs that participate in the JNK
pathways was not nonspecific phosphorylation; rather, these
MEK members are direct substrates of dMLK.
4. Discussion
JNK signaling cascade represents one subgroup of
MAPKs that are primarily activated in response to envi-
ronmental stresses and inflammatory cytokines [29]. Com-
plexity and diversity of JNK signaling increases because
more than one JNKKK (MAPKKK) can activate each
JNKK (MAPKK) [1]. To counter this problem of redun-
dancy in mammalian system, we decided to use Droso-
phila system, where a given protein is often represented by
a single homolog of its mammalian counterpart [17]. We
report here cloning, expression analysis and biochemical
characterization of a Drosophila homolog of mammalian
mixed lineage kinase, dMLK that is also known as slipper.
In Drosophila, JNK pathway plays a very significant role
during the development process. The mutational analyses
with the components of JNK pathway in Drosophila
indicate that an intact JNK pathway is required for
successful closure of dorsal epidermis [30]. The dorsal
open phenotype caused by mutations either in dJun, dJNK
or Hep led to premature death in Drosophila in the
embryonic stage [18]. So far, the MAPKKK in Drosophila
JNK pathway responsible for dorsal closure process was
unknown. Although the recent genetic analysis studies in
Drosophila identified slipper, an MLK [22], the biochem-
ical features including its identity as a MAPKKK member
and ability to directly phosphorylate MEK members and
its comprehensive expression profile were not reported.
Since others and we have shown that members of the
MLKs are the potent activators of JNK in mammalian
system, we hypothesized that a homolog of mammalian
MLKs in Drosophila might act as MAPKKK in the JNK
pathway. In mammals, besides MLKs, other members of
MAPKKK, for example TAK1, ASK1, MEKK 1–4 and
Tpl2, have also been shown to activate JNK pathway [31].
Recently, a Drosophila TAK1, dTAK1, has been cloned
and analyses of dTAK1 mutants revealed that dTak1 does
not play a major role in dorsal closure [32]. The Droso-
phila homolog of mammalian MEKK1 has been reported
to specifically activate p38 MAPK in response to environ-
mental stresses, proving that dMEKK1 was also not
involved in the JNK pathway unlike its mammalian
counterpart [33]. The ability of dMLK/slipper to directly
phosphorylate Hep and dMKK4 and activate dJNK in vivo
and its subsequent role in dorsal closure process [22] place
dMLK/slipper as the first reported MAPKKK in the dJNK
pathway in Drosophila.
The sequence analysis revealed that dMLK/slipper has
high homology to the mammalian MLKs, especially in the
kinase domain and is very close to mammalian MLK2. The
dMLK showed all the unique features of mammalian MLKs
including SH3 domain, a hybrid kinase domain, leucine
zipper motif and CRIB domain (Fig. 1B). The N terminus of
dMLK is unique and contains a stretch of 10 glutamines
whose function is yet to be determined. The other unique
features of dMLK are the presence of a threonine and
asparagine region next to the CRIB domain and a quite
divergent C-terminus tail, which is absent in mammalian
MLKs (Fig. 1B). The functional significance of glutamine
and the threonine/asparagine regions is not known at this
stage.
Developmental expression pattern of dMLK points that
there is a high level of maternal deposition of dMLK similar
to dMEKK1 [33], dMKK3 and dp38 [28]. Expression of
dMLK in Drosophila adult brain indicates that like its
mammalian counterpart, dMLK may have a role in specific
neuronal functions. Overexpression of MLK3 in neuronal
cells causes apoptosis, similar to Parkinson’s disease, which
can be blocked by MLKs inhibitor, CEP-1347 [34,35].
Mammalian MLK2 and MLK3 are associated with post-
synaptic density protein (PSD-95) and kainate receptor
glutamate receptor 6 (GluR6) in intact neuronal cells and
in rat brain tissues, and induce JNK-mediated neuronal cell
death similar to Huntington’s disease [36]. Drosophila as a
model has been useful towards elucidating mechanisms of
human neurodegenerative disease, including Alzheimer’s,
Parkinson’s and Huntington’s diseases [37]. Use of misex-
pression [23] or suppressor screen [38] analysis in Droso-
phila may provide insight to understand the role of
mammalian MLKs in normal as well as pathological con-
ditions.
It has been shown earlier that mammalian MLKs act as
MAPKKK and their overexpression in mammalian cells
activates JNK pathway. Overexpression of MLKs has also
been shown to activate p38 and ERK pathways. The over-
expression studies indeed provide some initial insight about
the functions of any such protein but a nonspecific activa-
tion as a consequence of overexpression cannot be ruled out.
Specific disruption of dMLK transcripts by using dMLK
RNAi will probably answer the role of dMLK in MAPK
activation in response to specific stimuli.
We have reported earlier that MLK3 directly phosphor-
ylates SEK1/MKK4 and MKK7 in vitro. The recombinant
dMLK produced in either mammalian or Drosophila cells
also phosphorylated both mammalian SEK1/MKK4 and
MKK7 or Drosophila Hep and dMKK4, and therefore it
is prudent to classify dMLK as a MAPKKK member. It has
been reported that dMKK4 can activate dJNK in Drosophila
but a genetic study involving dMKK4 in dJNK pathway is
still not reported [39]. It is possible that in vivo, dMKK4
and Hep are both targets of dMLK similar to the mammalian
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MEKs, where SEK1/MKK4 and MKK7 synergistically
activate JNK pathway [40]. Based on the protein structure
of dMLK and its ability to phosphorylate MEK members in
vitro, dMLK can therefore be designated as MAPKKK
family member like other mammalian MLKs [2,5].
In conclusion, we provide the first biochemical evidence
in Drosophila, which demonstrates that dMLK/slipper
directly phosphorylates Hep and dMKK4 and therefore
can be classified as a MAPKKK family member in the
activation of the Hep/Basket (JNK) pathway. Even though
overexpressed dMLK activated all three major MAPK path-
ways, it will be interesting to investigate its response to
various agonists and stress agents. Gene disruption studies
of dMLK using RNAi method in Drosophila S2 cells may
provide definitive answers to identify distinct stimuli that
regulate dMLK/slipper. Since JNK module is relatively
conserved between Drosophila and mammals, further stud-
ies should provide insight to understand the role of MLKs in
healthy and diseased states, especially in neurodegenerative
disorders.
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